Roche has introduced cobas infinity edge, a secure and encrypted cloud-based platform for the integration and management of point of care data, available for use in clinical settings globally.
California-based Penumbra has released their REAL Immersive System y-Series, expanding its comprehensive virtual reality-based healthcare platform with significantly more activities and experiences now available to help improve patient care, including clinical rehabilitation therapy. With TherapyView, an enhanced therapist interface, clinicians can customize therapy programmes based on individual needs to challenge, motivate and engage patients.
Mojo Vision, has made significant headway with its advanced prototype of Mojo Lens, the world’s first smart contact lens, including an array of new, industry-first features.
Kestra Medical Technologies, the developer of the ASSURE Wearable Cardioverter Defibrillator (WCD) system says a recent study shows the device is effective at reducing false-positive shock alarms.
FUJIFILM Healthcare Europe has unveiled ECHELON Smart Plus with ‘REALISE Plus’, a 1.5T MRI system with a new version of the SynergyDrive Automation Suite.
Omnicell has launched their IVX Station, an innovative solution designed to scale the benefits of leveraging IV robotic technology, making it accessible to the mainstream market.
DexCom has unveiled their new Dexcom ONE Continuous Glucose Monitoring System which will be launched in the United Kingdom in May. The Dexcom ONE system is an easy-to-use real-time CGM (rt-CGM) for people living with diabetes. Dexcom ONE is currently in review to be added to drug tariffs across the UK regions.
Nova Biomedical has launched the Nova Max Pro Creatinine/eGFR Meter System in all CE countries. Nova Max Pro is a new tool to improve kidney care through kidney function screening and early detection of kidney disease in point-of-care settings outside the hospital.
FUJIFILM Healthcare Europe previewed two new models in the ARIETTA diagnostic ultrasound range at ECR 2022 Overture, an online event that took place from March 2-6. The devices will be showcased on site at ECR 2022 in Vienna from July 13-17.
Carestream Health’s groundbreaking Smart Noise Cancellation (SNC) technology has received FDA 510(k) Clearance for its dose reduction capability. The artificial intelligence (AI)-based feature allows a user to reduce dose without loss of image quality.* SNC provides improved diagnostic quality, preservation of fine detail and better contrast-to-noise ratio for images acquired at clinically nominal exposures.
“Carestream is continuously focused on reducing radiation dose without sacrificing image quality,” said Ron Muscosky, Worldwide Product Line Manager at Carestream. “The results of this reader study are another proof point of the quality of our high-performance image capture systems. This improved capability to optimize radiation dose will be especially valuable in neonatal and pediatric diagnostic imaging, where imaging at the lowest possible dose is crucial for young patients.”
SNC addresses a long-standing challenge in medical imaging of separating noise from an image. Traditional noise reduction introduces blurring, which degrades image sharpness and might remove important anatomical information. Conversely, the more an image is sharpened, the more noise may be enhanced. Carestream’s SNC overcomes this gridlock by isolating noise to produce images that are significantly clearer than with standard processing.
“Our AI-powered Smart Noise Cancellation gives radiologists another important tool to adjust the amount of noise cancellation and exposure to meet their desired imaging quality to aid their diagnosis,” Muscosky added.
When combined with SmartGrid software, Smart Noise Cancellation technology promises benefits in gridless imaging where the removal of scatter typically leads to an increase in noise appearance.
Smart Noise Cancellation software is available as an option with Carestream’s ImageView Software powered by Eclipse — the intelligent image-processing engine behind the company’s innovative imaging software. SNC is currently available on Carestream’s DRX-Evolution and DRX-Evolution Plus systems.
*These statements were verified using Carestream detectors in a reader study performed by board certified radiologists comparing pairwise images taken at nominal dose (CsI ISO 400 speed / GOS ISO 320 speed) and reduced dose (CsI ISO 800 speed / GOS ISO 500 speed) with SNC.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
